Venture Capital Deals and Investments
  • All Technology
  • AI
  • Autonomy
  • B2B Growth
  • Big Data
  • BioTech
  • ClimateTech
  • Consumer Tech
  • Crypto
  • Cybersecurity
  • DevOps
  • Digital Marketing
  • Ecommerce
  • EdTech
  • Enterprise
  • FinTech
  • GovTech
  • Hardware
  • HealthTech
  • HRTech
  • LegalTech
  • Nanotech
  • PropTech
  • Quantum
  • Robotics
  • SaaS
  • SpaceTech
AllNewsDealsSocialBlogsVideosPodcastsDigests

Venture Capital Pulse

EMAIL DIGESTS

Daily

Every morning

Weekly

Sunday recap

NewsDealsSocialBlogsVideosPodcasts
Courage Therapeutics Secures $11M Seed Round Led by Arsenal Bridge Ventures
SeedVenture Capital

Courage Therapeutics Secures $11M Seed Round Led by Arsenal Bridge Ventures

•November 3, 2025
•Nov 3, 2025
0

Participants

Courage Therapeutics

Courage Therapeutics

company

Arsenal Bridge Ventures

Arsenal Bridge Ventures

investor

Why It Matters

The infusion of seed capital enables Courage Therapeutics to accelerate R&D on high‑need obesity and wasting disease treatments, a market projected to grow sharply as prevalence rises. Investor backing signals confidence in the company’s approach and may attract further funding for later‑stage trials.

Deal Summary

Courage Therapeutics announced the closing of a seed financing round exceeding $11 million, led by venture firm Arsenal Bridge Ventures and supported by existing backers. The funding will accelerate development of novel treatments for genetic and dietary obesity and wasting diseases.

0

Comments

Want to join the conversation?

Loading comments...